News

Orange Health Labs Has Raised Rs 277 Crore Series C Led by Iron Pillar — Bengaluru Diagnostics Startup Hits $77M in Total Funding

By Darshan S, Editor · 25 June, 2026 · 2 min read

Darshan S, Editor — Orange Health Labs Has Raised Rs 277 Crore Series C Led by Iron Pillar — Bengaluru Diagnostics Startup Hits $77M in Total Funding

Summary

  • Orange Health Labs Raises Rs 277 Crore Series C Led by Iron Pillar India — Bengaluru Diagnostics Platform Hits $205M Valuation
  • Bengaluru-based Orange Health Labs has closed a Rs 277 crore ($30M) Series C led by Iron Pillar India. Post-money valuation $205M. Total funding approaches $77M. Bengaluru operations profitable.

"When we started Orange Health in 2020, the idea was simple: make diagnostics faster, more accessible, and as convenient as ordering your morning coffee. This round is fuel for our next big leap — expanding services, reaching more homes, and building a stronger team."

Orange Health Labs, the Bengaluru-based full-stack diagnostics platform, has raised Rs 277 crore — approximately $30 million — in a Series C funding round led by Iron Pillar India, per regulatory filings reviewed by Entrackr on June 22, 2026. The round values Orange Health Labs at approximately Rs 1,950 crore ($205 million) post-money, and brings total funding since its December 2020 founding to approximately $77 million.

Iron Pillar India leads with Rs 156 crore ($16 million). New investors Good Capital (Rs 15.5 crore) and Paramark Frontier Fund (Rs 37 crore) join the cap table alongside Crescent Enterprises (Rs 37.7 crore). Existing investors Bertelsmann, Accel India, and General Catalyst also participate. Accel India retains its position as largest external shareholder at 15.49%. Iron Pillar enters with an 8% ownership stake. The round arrives 18 months after the December 2024 Series B-extension round led by Amazon Smbhav Venture Fund.

What Orange Health Labs Does

Orange Health Labs operates a full-stack at-home diagnostics platform built around a 30-minute sample collection from home and 6-hour report turnaround — a service standard that has become its commercial differentiator in a market where the dominant incumbents (Dr Lal PathLabs, Metropolis, Thyrocare) have historically prioritised cost over convenience and speed. The company runs six accredited processing laboratories, partners with more than 1,000 clinics, and operates across Bengaluru, Delhi, Gurugram, Noida, Ghaziabad, Mumbai, and Hyderabad.

The operational achievement that underpins the Series C investor thesis is Bengaluru profitability — Orange Health Labs has demonstrated that its unit economics work in its home market, providing the template for expansion into additional cities. At-home diagnostics is an operationally demanding business: phlebotomist workforce management, laboratory accreditation, cold chain logistics, and digital report delivery must all function simultaneously and reliably at the standard that justifies a premium over walk-in services. Bengaluru profitability validates that this is achievable.

FY25 Financials and Growth Trajectory

Orange Health Labs reported revenue of Rs 84 crore for FY25 with a loss of Rs 81 crore — a loss profile consistent with a business investing in geographic expansion, workforce scaling, and infrastructure ahead of the revenue growth that follows. The company has referenced an annual revenue run rate of Rs 100 crore and a 100% year-on-year growth target in co-founder communications. FY26 results have not yet been filed. The 18-month capital-efficient period between funding rounds suggests Orange Health was focused on operational consolidation and Bengaluru profitability rather than aggressive multi-city burn.

Orange One and the Preventive Health Pivot

In January 2026, Orange Health Labs launched Orange One — a preventive health subscription that repositions the company from transactional diagnostics toward a managed preventive health relationship. Orange One provides bundled annual health testing packages with ongoing monitoring, connecting the company's at-home collection infrastructure to a recurring revenue model. The preventive health pivot directly aligns Orange Health with the broader Indian healthcare market trend — exemplified by CENT's clinical prevention centres covered earlier in this edition — where consumers are increasingly seeking proactive health management rather than waiting for symptoms.

The Bengaluru Diagnostics Ecosystem

Orange Health Labs is one of several Bengaluru-headquartered diagnostics companies BHC Media has covered in 2026. Thyrocare's SecondMedic partnership for tier-2 expansion (June 11), Remidio's Gates Foundation grant for AI retinal maternal screening (June 11), and now Orange Health's Series C — together they represent a Bengaluru diagnostics ecosystem that is simultaneously extending geographic reach, deploying AI, and building the preventive health infrastructure India has historically lacked.

"BHC Perspective"

At Bengaluru Health Community, the Orange Health Labs Series C is a home story. A Bengaluru diagnostics startup that launched in 2020 is now a $205 million business with $77 million in total funding — having built Bengaluru profitability from scratch in six years. BHC previously drafted a partnership outreach to Orange Health Labs exploring event co-branding, community discounts, and media coverage. This Series C makes that conversation more timely than ever. For BHC founders in diagnostics, at-home healthcare, or preventive health — Orange Health's trajectory is the commercial model.

Frequently Asked Questions

Q: What has Orange Health Labs raised?
A: Rs 277 crore ($30M) Series C led by Iron Pillar India (Rs 156 crore), with Crescent Enterprises, Good Capital, Paramark Frontier Fund, Bertelsmann, Accel India, and General Catalyst also participating. Post-money valuation: Rs 1,950 crore ($205M). Total funding: ~$77M.

Q: What does Orange Health Labs do?
A: A Bengaluru-based full-stack at-home diagnostics platform — 30-minute sample collection, 6-hour report turnaround, 6 accredited labs, 1,000+ clinic partners. Operating in Bengaluru, Delhi, Gurugram, Noida, Ghaziabad, Mumbai, and Hyderabad. Bengaluru operations are profitable.

Q: What is Orange One?
A: Orange Health Labs' preventive health subscription launched January 2026 — bundled annual health testing packages with ongoing monitoring, repositioning the company from transactional diagnostics toward a recurring preventive health relationship model with a more stable revenue profile.